207 related articles for article (PubMed ID: 37537076)
21. Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis.
Wang H; Wang Y; Liu H; Li X; Sun C; Pang Z; Zhang B; Hu Y
Int J Pharm; 2024 May; 657():124127. PubMed ID: 38621611
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hemolytic anemia: An unusual presentation of hemophagocytic lymphohistiocytosis in a pediatric post-liver transplant patient.
Jarchin L; Chu J; Januska M; Merola P; Arnon R
Pediatr Transplant; 2018 Nov; 22(7):e13281. PubMed ID: 30129086
[TBL] [Abstract][Full Text] [Related]
23. Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M
Immunol Med; 2021 Dec; 44(4):237-245. PubMed ID: 33982649
[TBL] [Abstract][Full Text] [Related]
24. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
[TBL] [Abstract][Full Text] [Related]
25. Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists.
Carter-Febres M; Lozano-Chinga M; Thomsen W; Treemarcki EB; James KE; Fluchel M
J Pediatr; 2023 Apr; 255():65-71.e6. PubMed ID: 36328191
[TBL] [Abstract][Full Text] [Related]
26. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
Hakim NN; Chi J; Olazagasti C; Liu JM
Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
[TBL] [Abstract][Full Text] [Related]
27. Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
He L; Yao S; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Front Immunol; 2022; 13():955523. PubMed ID: 36189240
[TBL] [Abstract][Full Text] [Related]
28. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
Amir AZ; Ling SC; Naqvi A; Weitzman S; Fecteau A; Grant D; Ghanekar A; Cattral M; Nalli N; Cutz E; Kamath B; Jones N; De Angelis M; Ng V; Avitzur Y
Liver Transpl; 2016 Sep; 22(9):1245-53. PubMed ID: 27216884
[TBL] [Abstract][Full Text] [Related]
29. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
Liu JM; Chi J
Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice.
Yoshihara S; Li Y; Xia J; Danzl N; Sykes M; Yang YG
Front Immunol; 2019; 10():186. PubMed ID: 30814997
[TBL] [Abstract][Full Text] [Related]
32. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
[TBL] [Abstract][Full Text] [Related]
33. Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis.
Zhang HQ; Yang SW; Fu YC; Chen MC; Yang CH; Yang MH; Liu XD; He QN; Jiang H; Zhao MY
Immunol Res; 2022 Oct; 70(5):566-577. PubMed ID: 35819695
[TBL] [Abstract][Full Text] [Related]
34. [Precise diagnosis and treatment of hemophagocytic lymphohistiocytosis guided by cytokine patterns].
Xu XJ; Tang YM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2142-2147. PubMed ID: 35872577
[TBL] [Abstract][Full Text] [Related]
35. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
37. Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report.
Peterlin P; Garnier A; Le Bourgeois A; Jullien M; Seguin A; Eveillard M; Béné MC; Guillaume T; Chevallier P
Acta Haematol; 2022; 145(5):537-541. PubMed ID: 35724631
[TBL] [Abstract][Full Text] [Related]
38. Advances in understanding the pathogenesis of HLH.
Usmani GN; Woda BA; Newburger PE
Br J Haematol; 2013 Jun; 161(5):609-622. PubMed ID: 23577835
[TBL] [Abstract][Full Text] [Related]
39. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic significance of Th1/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis].
Xu XJ; Tang YM; Zhao N; Song H; Yang SL; Shi SW; Xu WQ; Pan BH; Zhang LY; Mao JQ; Shen HP; Gu ME; Xia J
Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):685-9. PubMed ID: 22176904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
